Black Diamond Therapeutics Inc (BDTX)

Apr 19, 2025

Head-To-Head Contrast: Avalon GloboCare (NASDAQ:ALBT) and Black Diamond Therapeutics (NASDAQ:BDTX) - Defense World

Apr 19, 2025

Apr 15, 2025

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Wellington Management Group LLP - Defense World

Apr 15, 2025

Apr 14, 2025

Raymond James Financial Inc. Purchases New Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Apr 14, 2025

Apr 13, 2025

Sei Investments Co. Purchases Shares of 22,802 Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Apr 13, 2025

Apr 04, 2025

Black Diamond stock hits 52-week low at $1.42 amid challenges - Investing.com India

Apr 04, 2025

Apr 04, 2025

Black Diamond stock hits 52-week low at $1.42 amid challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

Mar 31, 2025

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Mar 31, 2025

Mar 29, 2025

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Stock Holdings Raised by Intech Investment Management LLC - The AM Reporter

Mar 29, 2025

Mar 28, 2025

Bank of New York Mellon Corp Purchases 65,341 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Mar 28, 2025

Mar 28, 2025

Black Diamond Therapeutics’ Global Licensing Deal with Servier - Global Legal Chronicle

Mar 28, 2025

Mar 26, 2025

BDTX stock touches 52-week low at $1.59 amid market challenges - Investing.com Australia

Mar 26, 2025

Mar 25, 2025

Black Diamond Therapeutics Trades Well Below Cash After Lucrative Deal With Servier - Seeking Alpha

Mar 25, 2025

Mar 24, 2025

What is Wedbush’s Estimate for BDTX Q1 Earnings? - Defense World

Mar 24, 2025

Mar 23, 2025

Connor Clark & Lunn Investment Management Ltd. Sells 37,472 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Mar 23, 2025

Mar 22, 2025

BB Biotech AG Reduces Stake in Black Diamond Therapeutics Inc - GuruFocus

Mar 22, 2025

Mar 21, 2025

Black Diamond Therapeutic Stock Price, Quotes and Forecasts | NASDAQ:BDTX - Benzinga

Mar 21, 2025

Mar 21, 2025

Stock Traders Buy High Volume of Call Options on Black Diamond Therapeutics (NASDAQ:BDTX) - Defense World

Mar 21, 2025

Mar 21, 2025

Growth Stocks To Add to Your Watchlist – March 19th - Defense World

Mar 21, 2025

Mar 21, 2025

Black Diamond Therapeutics (NASDAQ:BDTX) Earns “Outperform” Rating from Wedbush - Defense World

Mar 21, 2025

Mar 21, 2025

HC Wainwright Has Bearish Forecast for BDTX Q1 Earnings - Defense World

Mar 21, 2025

Mar 20, 2025

Black Diamond Therapeutics sees $11.99m stock sale by BB Biotech AG - Investing.com

Mar 20, 2025

Mar 20, 2025

Growth Stocks To Add to Your WatchlistMarch 19th - MarketBeat

Mar 20, 2025

Mar 19, 2025

Black Diamond Therapeutics Surge: Savvy Move or Bubble? - timothysykes.com

Mar 19, 2025

Mar 19, 2025

Black Diamond Gets The Gift Of Time In License Pact With Servier - insights.citeline.com

Mar 19, 2025

Mar 19, 2025

Servier and Black Diamond enter oncology licensing deal By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, a Targeted Oncology Therapy - Marketscreener.com

Mar 19, 2025

Mar 19, 2025

Sector Update: Health Care -March 19, 2025 at 03:43 pm EDT - Marketscreener.com

Mar 19, 2025

Mar 19, 2025

Black Diamond Therapeutics Shares Jump On New Partnership With France-Based Servier: Retail Sentiment Hits Year-High - NewsBreak: Local News & Alerts

Mar 19, 2025

Mar 19, 2025

This Biotech Is Finding Mid-Week Success Following Licensing Agreement Announcement - The Globe and Mail

Mar 19, 2025

Mar 19, 2025

Black Diamond Therapeutics Shares Jump On New Partnership With France-Based Servier: Retail Sentiment Hits Yea - Asianet Newsable

Mar 19, 2025

Mar 19, 2025

Black Diamond Therapeutics surges on licensing deal - MSN

Mar 19, 2025

Mar 19, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Mar 19, 2025

Mar 19, 2025

Black Diamond Therapeutics Inks Licensing Pact With French Pharma Firm Servier For Its Early-Stage Cancer Drug Worth Over $700 Million - Benzinga

Mar 19, 2025

Mar 19, 2025

Black Diamond Therapeutics (BDTX) Stock Jumps After Entering Licensing Deal - Stocks Telegraph

Mar 19, 2025

Mar 19, 2025

Black Diamond stock surges on licensing deal (BDTX:NASDAQ) - Seeking Alpha

Mar 19, 2025

Mar 19, 2025

Servier and Black Diamond collaborate on BDTX-4933 - The Pharma Letter

Mar 19, 2025

Mar 19, 2025

Black Diamond Therapeutics, Servier Sign Global Licensing Deal for BDTX-4933 to Treat Solid Tumors - Marketscreener.com

Mar 19, 2025

Mar 19, 2025

Servier and Black Diamond enter oncology licensing deal - Investing.com India

Mar 19, 2025

Mar 19, 2025

Black Diamond rises on licensing deal for tumor treatment - TradingView

Mar 19, 2025

Mar 19, 2025

Black Diamond stock soars on licensing deal By Investing.com - Investing.com Australia

Mar 19, 2025

Mar 19, 2025

Servier And Black Diamond Therapeutics Announce Global Licensing Agreement For BDTX-4933, A Targeted Oncology Therapy - Marketscreener.com

Mar 19, 2025

Mar 19, 2025

Servier and Black Diamond Therapeutics Announce Global - GlobeNewswire

Mar 19, 2025

Mar 19, 2025

HC Wainwright Issues Positive Forecast for Black Diamond Therapeutics (NASDAQ:BDTX) Stock Price - Defense World

Mar 19, 2025